SANDOVAL DAVID I. (General Counsel) sold 0.5% of their position (353.00 shares) of MAXCYTE, INC. on the open market
Open‑market sale worth $1.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/20/2025ACC: 0000905148-25-000985
Officer· General Counsel
Since Feb 2024
-353.00
Net shares
Net seller
$1.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
353.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−353.00
Price / share
$3.18
Trade value
$1.12K
% of position
0.5%
3/18/2025
64.57K→64.22K
Total
Net shares
−353.00
Net value
-$1.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2025 | S · Sale | −353.00 | $3.18 | $1.12K | 0.5% | 64.57K | 64.22K |
| Total | −353.00 | -$1.12K | ||||||
Derivative Transactions0
No derivative transactions reported